Cardiac Toxicity and Prognostic Value of New Echocardiographic Indicators in the Treatment of Primary Multiple Myeloma
Condition:   Multiple Myeloma Intervention:   Other: Chemotherapy and/or autologous hematopoietic stem cell transplantation Sponsor:   Qilu Hospital of Shandong University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 15, 2023 Category: Research Source Type: clinical trials